First in Human Study to Evaluate the Safety, Tolerability of HH30134 in Advanced Solid Tumors

NCT04746612 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

22

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor business decision

Conditions

Advanced Solid Tumors

Interventions

DRUG: HH30134

Sponsor

Haihe Biopharma Co., Ltd.